A previous study by us found better tear stability, lesser ocular surface epithelial damage, and higher goblet cell densities when 3% diquafosol sodium (mucin and water secretagogue) eye drops were started at the time of the commencement of anti-glaucoma eye drops [14]. This evidence concerns the gene MUC5AC and glaucoma.